...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
Reply New Message
Back To Forum List View
Icon president A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
8
BearDownAZ
Oct 26, 2020 08:15AM
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
4
fuzzyjr
Oct 26, 2020 08:26AM
Apabetalone and Potential COVID-19 Effectiveness
12
masila
Oct 26, 2020 09:01AM

Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms

posted on Oct 26, 2020 10:32AM
Log in to use the IP Check tool [?]

If I were a potential BP partner with RVX, I would probably want to time any partnering announcement with a major conference event....let's say for example...the AHA.   just a thought

6 Recommendations
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
8
jermainejackson
Oct 26, 2020 11:00AM
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
7
KOO-KOO2
Oct 26, 2020 02:04PM
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
5
cityslicker99
Oct 26, 2020 03:59PM
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
8
barsax
Oct 26, 2020 04:18PM
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
4
cityslicker99
Oct 26, 2020 06:11PM
Icon president Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
2
tada
Oct 26, 2020 08:55PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply